Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency. (2014)

First Author: Carbonaro DA
Attributed to:  Development of a lentiviral vector for gene therapy of ADA deficiency funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/mt.2013.265

PubMed Identifier: 24256635

Publication URI: http://europepmc.org/abstract/MED/24256635

Type: Journal Article/Review

Volume: 22

Parent Publication: Molecular therapy : the journal of the American Society of Gene Therapy

Issue: 3

ISSN: 1525-0016